Skip to main content

News

Teva Pharma appoints Eli Kalif to succeed Michael McClellan as CFO

By Nasdaq  
   November 07, 2019

Israeli generic medicines producer Teva Pharmaceutical Industries Ltd. announced Thursday the appointment of Eli Kalif as Executive Vice President and Chief Financial Officer, effective December 22, 2019. Kalif will be based out of Teva's global headquarters in Israel. Kalif joins Teva with broad experience in corporate and operational finance, most recently as Senior Vice President, Finance, leading the finance organization that supports the Global Operations, Components & services business at Flex Ltd.

Full story


Get the latest on healthcare leadership in your inbox.